Cargando…
A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer’s disease and Parkinson’s disease
BACKGROUND: Disease-modification clinical trials in neurodegenerative disorders have struggled to separate symptomatic effects of putative agents from disease-modification. In response, a variety of clinical trial designs have been developed. A systematic review was undertaken to examine which trial...
Autores principales: | McGhee, David J. M., Ritchie, Craig W., Zajicek, John P., Counsell, Carl E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910262/ https://www.ncbi.nlm.nih.gov/pubmed/27312378 http://dx.doi.org/10.1186/s12883-016-0606-3 |
Ejemplares similares
-
Using ‘dead or dependent’ as an outcome measure in clinical trials in Parkinson's disease
por: McGhee, David, et al.
Publicado: (2015) -
A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease
por: McGhee, David J. M., et al.
Publicado: (2014) -
A systematic review of biomarkers for disease progression in Parkinson’s disease
por: McGhee, David JM, et al.
Publicado: (2013) -
Predictors of functional dependency in Parkinson's disease
por: Macleod, Angus D., et al.
Publicado: (2016) -
Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical Trial
por: Stevens, Kara N., et al.
Publicado: (2022)